This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Comment on “Lithium and Clozapine Rechallenge: A Retrospective Case Analysis.”

Richard A. Kanaan, MRCPsych

Published: April 16, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We are grateful to Dr. Esposito for his comments on distinguishing benign from malignant neutropenia. We agree that tests to distinguish the two may be of considerable benefit to clinical decision making where continuing with clozapine is a possibility. However, as our article1 describes, the rules in the United Kingdom are quite strict about clozapine prescription, so that persevering with clozapine despite the occurrence of a neutropenia is not normally possible.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 68

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Meta-Analysis

Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis

Although effects on weight gain have been explored for several antipsychotics, the role of dose in producing...

Read More...